Search Result "osteoclastic-activating factors"
Regulation of Apoptosis and Activity of the Osteoclast
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 10 Issue: 2 Year: 2010 Page: 100-107
Author(s): Tsuyoshi Miyazaki, Sakae Tanaka
The Cross-over of Anticancer Agents with Osteoclast Activities
Journal: Current Cancer Therapy Reviews
Volume: 7 Issue: 4 Year: 2011 Page: 290-302
Author(s): Henning M. Schramm
Tocotrienols Regulate Bone Loss through Suppression on Osteoclast Differentiation and Activity: A Systematic Review
Journal: Current Drug Targets
Volume: 19 Issue: 9 Year: 2018 Page: 1095-1107
Author(s): Nur Fathiah Mohd Radzi,Noor Akmal Shareela Ismail,Ekram Alias
Understanding and Targeting Osteoclastic Activity in Prostate Cancer Bone Metastases
Journal: Current Molecular Medicine
Volume: 13 Issue: 4 Year: 2013 Page: 626-639
Author(s): J.L. Sottnik, E.T. Keller
Hepatocyte Growth Factor in Normal and Diseased Bone and Joint Tissues
Journal: Current Rheumatology Reviews
Volume: 2 Issue: 1 Year: 2006 Page: 1-7
Author(s): Iannis E. Adamopoulos, Nicholas A. Athanasou
Novel Targets of Vitamin D Activity in Bone: Action of the Vitamin D Receptor in Osteoblasts, Osteocytes and Osteoclasts
Journal: Current Drug Targets
Volume: 14 Issue: 14 Year: 2013 Page: 1683-1688
Author(s): Jackson W Ryan,Daniel Reinke,Masakazu Kogawa,Andrew G Turner,Gerald J Atkins,Paul H Anderson,Howard A Morris
Inhibitory Effects of Cathepsin K Inhibitor (ODN-MK-0822) on the Paracrine Pro-Osteoclast Factors of Breast Cancer Cells
Journal: Current Molecular Pharmacology
Volume: 14 Issue: 6 Year: 2021 Page: 1134-1145
Author(s): Yaongamphi Vashum,Amuthavalli Kottaiswamy,Giridharan Bupesh,Riya P. Singh,Parkavi Kalaiselvan,K. Thiagarajan,Shila Samuel
Osteoclast Apoptosis in Rheumatic Diseases Characterized by a High Level of Bone Resorption (Osteoporosis, Rheumatoid Arthritis, Myeloma and Pagets Disease of Bone)
Journal: Current Rheumatology Reviews
Volume: 5 Issue: 2 Year: 2009 Page: 98-110
Author(s): Sophie Roux, Jacques P. Brown
Osteoprotegerin A Physiological and Pharmacological Inhibitor of Bone Resorption.
Journal: Current Pharmaceutical Design
Volume: 7 Issue: 8 Year: 2001 Page: 613-635
Author(s): Paul J. Kostenuik, victoria Shalhoub
Natural Occurring Compounds Inhibit Osteoclastogenesis via Targeting NFATc1-related Signaling Pathways
Journal: Current Drug Targets
Volume: 21 Issue: 4 Year: 2020 Page: 358-364
Author(s): Jun Wang,Haishi Zheng,Rui Ma